CIK 0001388320 · Non-accelerated filer<br>Smaller reporting company
Actinium Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ATNM
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880378336
- Phone
- (646) 677-3870
- Business address
- 100 PARK AVE., 23RD FLOOR, NEW YORK, NY, 10017
- Former names
- Cactus Ventures, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-07-12 | Shetty Ajit Director | Grant or award · Options to purchase common stock | +250,000 | $0.23 | $58K | 250,000 |
| 2019-07-12 | Nicholson, C. David Director | Grant or award · Options to purchase common stock | +250,000 | $0.23 | $58K | 250,000 |
| 2019-03-05 | Berger Mark Stanley Chief Medical Officer | Option exercise | +3,500 | $0.60 | $2K | 22,500 |
| 2019-02-21 | SETH SANDESH Chairman & CEO | Option exercise | +8,125 | $0.60 | $5K | 161,458 |
| 2018-12-10 | SETH SANDESH Chairman & CEO | Purchase | +10,000 | $0.44 | $4K | 153,333 |
| 2018-12-10 | O'Loughlin Steve Principal Financial Officer | Purchase | +10,000 | $0.44 | $4K | 35,500 |
| 2018-11-19 | Ludwig Dale L. Chief Scientific Officer | Purchase | +10,000 | $0.45 | $4K | 10,000 |
| 2018-07-17 | SETH SANDESH CEO | Purchase | +10,000 | $0.79 | $8K | 143,333 |
| 2018-07-13 | Nicholson, C. David Director | Grant or award · Options to purchase common stock | +75,000 | $0.78 | $59K | 75,000 |
| 2018-07-13 | Chell Jeffrey W. Director | Grant or award · Options to purchase common stock | +75,000 | $0.78 | $59K | 75,000 |
| 2018-07-13 | Ray Nitya G. Executive VP | Grant or award · Options to purchase common stock | +75,000 | $0.78 | $59K | 75,000 |
| 2018-07-13 | Berger Mark Stanley Chief Medical Officer | Grant or award · Options to purchase common stock | +250,000 | $0.78 | $196K | 250,000 |
| 2018-07-13 | SETH SANDESH CEO | Grant or award · Options to purchase common stock | +1,000,000 | $0.78 | $783K | 1,000,000 |
| 2018-07-13 | O'Loughlin Steve Principal Financial Officer | Grant or award · Options to purchase common stock | +265,000 | $0.78 | $207K | 265,000 |
| 2018-07-13 | Shetty Ajit Director | Grant or award · Options to purchase common stock | +75,000 | $0.78 | $59K | 75,000 |
| 2018-07-13 | Steinhart Richard I Director | Grant or award · Options to purchase common stock | +75,000 | $0.78 | $59K | 75,000 |
| 2018-06-15 | O'Loughlin Steve Principal Financial Officer | Purchase | +12,000 | $0.50 | $6K | 25,500 |
| 2018-04-19 | SETH SANDESH Chairman & CEO | Purchase | +5,000 | $0.38 | $2K | 133,333 |
| 2018-03-06 | Berger Mark Stanley Chief Medical Officer | Other acquisition | +14,000 | $0.50 | $7K | 19,000 |
| 2018-03-06 | Berger Mark Stanley Chief Medical Officer | Other acquisition · Series A Warrants | +3,500 | $0.50 | $2K | 3,500 |
Page 6 of 16 · 316 trades